| Name: | Vitruvias Therapeutics, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 18 Jun 2024 (8 months ago) |
| Branch of: | Vitruvias Therapeutics, Inc., ALABAMA (Company Number 000-313-304) |
| Entity Number: | 10274395 |
| Place of Formation: | ALABAMA |
| Address: | 778 N DEAN ROAD STE 600, AUBURN, AL 36830 |
| Name | Role |
|---|---|
| Bryce Harvey | Shareholder |
| Carl Whatley | Director |
| Carl Whatley | Shareholder |
| Perceptive Life Sciences Master Fund Ltd.-Michael Altman | Director |
| Perceptive Life Sciences Master Fund Ltd.-Michael Altman | Shareholder |
| JW Partners, LP | Director |
| JW Partners, LP | Shareholder |
| C T Corporation System | Registered Agent |
| License Number | Program | Type | Status | Issue Date | Effective Date | Expiration Date |
|---|---|---|---|---|---|---|
| 162404 | Pharmacy | Manufacturer | Active | 2020-06-09 | 2024-06-27 | 2026-06-30 |
Date of last update: 03 Feb 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
